PHARMACOLOGICAL ACTIONS OF THE MAIN METABOLITES OF DIHYDROERGOTAMINE

被引：48

作者：

MULLERSCHWEINITZER, E

机构：

来源：

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 1984年 / 26卷 / 06期

关键词：

D O I：

10.1007/BF00541928

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：699 / 705

页数：7

共 29 条

[1]

AELLIG WH, 1976, POSTGRAD MED J, V52, P21

[2] VENOCONSTRICTOR EFFECT OF DIHYDROERGOTAMINE IN SUPERFICIAL HAND VEINS [J].

AELLIG, WH .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1974, 7 (02) :137-139

[3] A NEW TECHNIQUE FOR RECORDING COMPLIANCE OF HUMAN HAND VEINS [J].

AELLIG, WH .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 11 (03) :237-243

[4]

AELLIG WH, 1977, INT J CLIN PHARM BI, V15, P106

[5] STUDIES OF EFFECT OF NATURAL AND SYNTHETIC POLYPEPTIDE TYPE ERGOT COMPOUNDS ON A PERIPHERAL VASCULAR BED [J].

AELLIG, WH ;

BERDE, B .

BRITISH JOURNAL OF PHARMACOLOGY, 1969, 36 (03) :561-+

[6] THE EFFECT OF ERGOT DERIVATIVES ON THE CIRCULATION IN MAN WITH SPECIAL REFERENCE TO 2 NEW HYDROGENATED COMPOUNDS (DIHYDROERGOTAMINE AND DIHYDROERGOCORNINE) [J].

BLUNTSCHLI, HJ ;

GOETZ, RH .

AMERICAN HEART JOURNAL, 1948, 35 (06) :873-894

[7] LOW ORAL BIOAVAILABILITY OF DIHYDROERGOTAMINE AND 1ST-PASS EXTRACTION IN PATIENTS WITH ORTHOSTATIC HYPOTENSION [J].

BOBIK, A ;

JENNINGS, G ;

SKEWS, H ;

ESLER, M ;

MCLEAN, A .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 30 (05) :673-679

[8]

BOBIK A, 1980, CLIN EXP PHARMACOL P, V7, P648

[9] *KLINISCH-EXPERIMENTELLE UNTERSUCHUNGEN UBER DIE KREISLAUFDYNAMISCHEN WIRKUNGEN DER DIHYDRIERTEN MUTTERKORNALKALOIDE [J].

DELIUS, L ;

HAMMERSCHMIDT, D ;

ODENTHAL, F .

KLINISCHE WOCHENSCHRIFT, 1949, 27 (1-2) :33-34

[10] DUAL EFFECT OF DIHYDROERGOTAMINE AND DIHYDROERGOTOXIN IN ISOLATED HUMAN FEMORAL VEINS AND ARTERIES [J].

GLUSA, E ;

MARKWARDT, F .

PHARMACOLOGY, 1982, 24 (05) :287-293

← 1 2 3 →